Bulk Inquiry
RET Inhibitor 2667
- Optical Purity: Optically pure
- Soluble in DMSO
- MF: C26H25FN10O
- MW: 512.54
Description
RET Inhibitor 2667 (CAS 1980023-80-0) is a potent RET inhibitor with an IC50 value below10 nM, displaying activity against wild-type RET and its mutants.
RET pharmacology is relevant to cancer and oncology; RET Inhibitor 2667 supports mechanistic studies of RET, RTK, GDNF in biochemical, cellular and disease-model assays.
Key Features
- RET inhibitor for interrogation of RET biology
- IC50 value
- Modulates RET-dependent downstream signaling and functional biological activity
- Supports focused RET pathway studies in biochemical and cellular systems
Applications
- Evaluating RET pharmacology and therapeutic target validation
- Probing RET-dependent pathways and intracellular cascades
- Investigating oncogenic mechanisms in breast and general cancers
- Profiling receptor signaling, ligand bindings, and biological actions
More Information
| Parent CAS No. | 1980023-80-0 |
|---|---|
| Chemical Name | (S)-N-(1-(6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethyl)-3-methyl-5-(4-methyl-6-(5-methyl-1H-pyrazol-3-ylamino)pyrimidin-2-yl)picolinamide |
| SMILES | C1(NC2=NNC(C)=C2)N=C(C2C=NC(C(=O)N[C@@H](C)C3C=CC(N4N=CC(F)=C4)=NC=3)=C(C)C=2)N=C(C)C=1 |&1:17,r| |
| MFCD | N.A. |
| InChi | InChI=1S/C26H25FN10O/c1-14-7-19(25-31-15(2)8-21(34-25)33-22-9-16(3)35-36-22)11-29-24(14)26(38)32-17(4)18-5-6-23(28-10-18)37-13-20(27)12-30-37/h5-13,17H,1-4H3,(H,32,38)(H2,31,33,34,35,36)/t17-/m0/s1 |
| InChiKey | DAFQECVJVSAYPF-KRWDZBQOSA-N |
| CID | 122487497 |
| Short Description | RET inhibitor |
Related Products
| AXON ID | NAME | FROM PRICE |
|---|---|---|
| 1411 | Vandetanib |
From $55.00 |
| 1819 | Cabozantinib S-malate |
From $66.00 |
| 3195 | Selpercatinib |
From $121.00 |
| 3226 | RET agonist Q525 |
From $132.00 |
| 3854 | BLU-667 |
From $143.00 |


